Randall Brower, DPM
Foot & Ankle Surgery · Phoenix, AZNPI 1689654030
Payments from drug & device makers
What this record shows
This record is dominated by other: $20,026 of the $20,387 with a category attached, or 98.2%. Medshape, Inc. accounts for 98.2% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2021 at $20,026 and has fallen 99.9% since, to $24 in 2025.
Across 11 payments — averaging $1853.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medshape, Inc.$20K
- Nevro Corp.$98
- Rikco International, LLC$88
- Smith+Nephew$58
- Angiodynamics, Inc.$50
- DJO, LLC$41
- plus $27 from 2 others
What the payments were for
- Food & beverage$2741%
- Education$880%
- Other$20,02698%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medshape, Inc. | 1 | $20,026 |
| Nevro Corp. | 1 | $98 |
| Rikco International, LLC | 2 | $88 |
| Smith+Nephew | 2 | $58 |
| Angiodynamics, Inc. | 1 | $50 |
| DJO, LLC | 2 | $41 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
| Orthofix Medical, Inc. | 1 | $10 |
How this compares
$20,387 in reported general payments places this provider in the 85th percentile of 291 foot & ankle surgery providers in Arizona.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Terbinafine Hcl | 57 | $1,214 |
| Celecoxib | 15 | $270 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 17 | $182 |
| Methylprednisolone | 19 | $123 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 16 | $72 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Phoenix
- Ryan ScottPhoenix$1.1M
- Jeffrey HolmesPhoenix$509K
- Melissa GalliPhoenix$324K
- Zachary FlynnPhoenix$239K
- Kyle VaughnPhoenix$110K
- David JaffePhoenix$75K
- Jason KaycePhoenix$57K
- Devin BlandPhoenix$49K
- Braden BoyerPhoenix$32K
- Martin WeismanPhoenix$31K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.